Literature DB >> 20942660

The paradoxical problem with multiple-IRB review.

Jerry Menikoff1.   

Abstract

Mesh：

Year:  2010        PMID： 20942660     DOI： 10.1056/NEJMp1005101

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  49 in total

1.  Ethical and practical challenges of sharing data from genome-wide association studies: the eMERGE Consortium experience.

Authors:  Amy L McGuire; Melissa Basford; Lynn G Dressler; Stephanie M Fullerton; Barbara A Koenig; Rongling Li; Cathy A McCarty; Erin Ramos; Maureen E Smith; Carol P Somkin; Carol Waudby; Wendy A Wolf; Ellen Wright Clayton
Journal:  Genome Res       Date:  2011-06-01       Impact factor: 9.043

2.  Ask not what your REB can do for you; ask what you can do for your REB.

Authors:  Ross E G Upshur
Journal:  Can Fam Physician       Date:  2011-10       Impact factor: 3.275

3.  Metrics survey of industry-sponsored clinical trials in Canada and comparator jurisdictions between 2005 and 2010.

Authors:  Jean-Marie Leclerc; Normand Laberge; Jean Marion
Journal:  Healthc Policy       Date:  2012-11

Review 4.  Institutional Review Boards: Purpose and Challenges.

Authors:  Christine Grady
Journal:  Chest       Date:  2015-11       Impact factor: 9.410

5.  The Clinical Trials Transformation Initiative: innovation through collaboration.

Authors:  Pamela Tenaerts; Leanne Madre; Patrick Archdeacon; Robert M Califf
Journal:  Nat Rev Drug Discov       Date:  2014-11       Impact factor: 84.694

Review 6.  Pragmatic Trials in Maintenance Dialysis: Perspectives from the Kidney Health Initiative.

Authors:  Laura M Dember; Patrick Archdeacon; Mahesh Krishnan; Eduardo Lacson; Shari M Ling; Prabir Roy-Chaudhury; Kimberly A Smith; Michael F Flessner
Journal:  J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 10.121

7.  Are central institutional review boards the solution? The National Heart, Lung, and Blood Institute Working Group's report on optimizing the IRB process.

Authors:  Alice M Mascette; Gordon R Bernard; Donna Dimichele; Jesse A Goldner; Robert Harrington; Paul A Harris; Hilary S Leeds; Thomas A Pearson; Bonnie Ramsey; Todd H Wagner
Journal:  Acad Med       Date:  2012-12       Impact factor: 6.893

8.  Review of multinational human subjects research: experience from the PHFI-Emory Center of Excellence partnership.

Authors:  Hemalatha Somsekhar; Dorairaj Prabhakaran; Nikhil Tandon; Rebecca Rousselle; Sarah Fisher; Aryeh D Stein
Journal:  Indian J Med Ethics       Date:  2012 Oct-Dec

9.  The efficiency of single institutional review board review in National Institute of Child Health and Human Development Cooperative Reproductive Medicine Network-initiated clinical trials.

Authors:  Michael P Diamond; Esther Eisenberg; Hao Huang; Christos Coutifaris; Richard S Legro; Karl R Hansen; Anne Z Steiner; Marcelle Cedars; Kurt Barnhart; Tracy Ziolek; Tracey R Thomas; Kate Maurer; Stephen A Krawetz; Robert A Wild; J C Trussell; Nanette Santoro; Heping Zhang
Journal:  Clin Trials       Date:  2018-10-24       Impact factor: 2.486

10.  Pilot randomized, non-inferiority, cross-over trial of once-weekly vs. three times-weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A.

Authors:  M V Ragni; J G Yabes; P F Fogarty; N C Josephson; C M Kessler; A T Neff; L Raffini; K Brummel-Ziedins; C G Moore
Journal:  Haemophilia       Date:  2016-12-11       Impact factor: 4.287
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.